These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33464392)

  • 1. Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial.
    Lucassen MJJ; Ter Wee MM; den Uyl D; Konijn NPC; Nurmohamed MT; Voskuyl AE; van Schaardenburg D; Kerstens PJSM; Bultink IEM; Boers M; Lems WF
    Osteoporos Int; 2021 Jul; 32(7):1441-1449. PubMed ID: 33464392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial.
    ter Wee MM; den Uyl D; Boers M; Kerstens P; Nurmohamed M; van Schaardenburg D; Voskuyl AE; Lems WF
    Ann Rheum Dis; 2015 Jun; 74(6):1233-40. PubMed ID: 24818633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention.
    Landewé RB; Boers M; Verhoeven AC; Westhovens R; van de Laar MA; Markusse HM; van Denderen JC; Westedt ML; Peeters AJ; Dijkmans BA; Jacobs P; Boonen A; van der Heijde DM; van der Linden S
    Arthritis Rheum; 2002 Feb; 46(2):347-56. PubMed ID: 11840436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-inferiority trial of an attenuated combination strategy ('COBRA-light') compared to the original COBRA strategy: clinical results after 26 weeks.
    den Uyl D; ter Wee M; Boers M; Kerstens P; Voskuyl A; Nurmohamed M; Raterman H; van Schaardenburg D; van Dillen N; Dijkmans B; Lems W
    Ann Rheum Dis; 2014 Jun; 73(6):1071-8. PubMed ID: 23606682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial high-dose prednisolone combination therapy using COBRA and COBRA-light in early rheumatoid arthritis.
    Rasch LA; van Tuyl LH; Lems WF; Boers M
    Neuroimmunomodulation; 2015; 22(1-2):51-6. PubMed ID: 25227967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis.
    Buckley LM; Leib ES; Cartularo KS; Vacek PM; Cooper SM
    J Rheumatol; 1997 Aug; 24(8):1489-94. PubMed ID: 9263140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial.
    Konijn NPC; van Tuyl LHD; Boers M; den Uyl D; Ter Wee MM; van der Wijden LKM; Bultink IEM; Kerstens PJSM; Voskuyl AE; van Schaardenburg D; Nurmohamed MT; Lems WF
    Rheumatology (Oxford); 2017 Sep; 56(9):1586-1596. PubMed ID: 28859326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in bone mineral density in premenopausal women with rheumatoid arthritis during a two-year follow-up.
    Hämäläinen H; Kaarela K; Kröger H; Kauppi M; Järvenpää S; Hakala M; Kotaniemi A
    Joint Bone Spine; 2007 Oct; 74(5):482-7. PubMed ID: 17905634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?
    van der Goes MC; Jacobs JW; Jurgens MS; Bakker MF; van der Veen MJ; van der Werf JH; Welsing PM; Bijlsma JW
    Osteoporos Int; 2013 Apr; 24(4):1429-36. PubMed ID: 23011680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone.
    Korthals-de Bos I; Van Tulder M; Boers M; Verhoeven AC; Adèr HJ; Bibo J; Boonen A; Van Der Linden S
    J Rheumatol; 2004 Sep; 31(9):1709-16. PubMed ID: 15338488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.
    Jensen TW; Hansen MS; Hørslev-Petersen K; Hyldstrup L; Abrahamsen B; Langdahl B; Zerahn B; Pødenphant J; Stengaard-Petersen K; Junker P; Østergaard M; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Lindegaard H; Jurik AG; Vestergaard A; Hetland ML;
    Ann Rheum Dis; 2014 Jun; 73(6):1123-9. PubMed ID: 23661492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis?
    van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Dijkmans BA; Boers M
    Ann Rheum Dis; 2007 Jul; 66(7):974-6. PubMed ID: 17392349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Low-Dose Disease-modifying Anti-rheumatics Drugs (DMARDs) on Bone Mineral Density of Premenopausal Women in Early Rheumatoid Arthritis.
    Rexhepi S; Rexhepi M; Sahatçiu-Meka V; Mahmutaj V; Boshnjaku S
    Med Arch; 2016 Apr; 70(2):101-3. PubMed ID: 27147781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis.
    van Tuyl LH; Boers M; Lems WF; Landewé RB; Han H; van der Linden S; van de Laar M; Westhovens R; van Denderen JC; Westedt ML; Peeters AJ; Jacobs P; Huizinga TW; van de Brink H; Dijkmans BA; Voskuyl AE
    Ann Rheum Dis; 2010 May; 69(5):807-12. PubMed ID: 19451137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone turnover, joint damage and bone mineral density in early rheumatoid arthritis treated with combination therapy including high-dose prednisolone.
    Verhoeven AC; Boers M; te Koppele JM; van der Laan WH; Markusse HM; Geusens P; van der Linden S
    Rheumatology (Oxford); 2001 Nov; 40(11):1231-7. PubMed ID: 11709606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA Trial Group. Combinatietherapie Bij Reumatoïde Artritis.
    Verhoeven AC; Bibo JC; Boers M; Engel GL; van der Linden S
    Br J Rheumatol; 1998 Oct; 37(10):1102-9. PubMed ID: 9825750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of bone mineral density and the occurrence of osteoporosis from 15 to 20 years of disease onset in patients with rheumatoid arthritis.
    Hämäläinen H; Kautiainen H; Kaarela K; Kotaniemi A
    Clin Exp Rheumatol; 2005; 23(2):193-8. PubMed ID: 15895889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
    Boers M; Verhoeven AC; Markusse HM; van de Laar MA; Westhovens R; van Denderen JC; van Zeben D; Dijkmans BA; Peeters AJ; Jacobs P; van den Brink HR; Schouten HJ; van der Heijde DM; Boonen A; van der Linden S
    Lancet; 1997 Aug; 350(9074):309-18. PubMed ID: 9251634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss.
    Wijbrandts CA; Klaasen R; Dijkgraaf MG; Gerlag DM; van Eck-Smit BL; Tak PP
    Ann Rheum Dis; 2009 Mar; 68(3):373-6. PubMed ID: 18408246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis.
    Tascioglu F; Oner C; Armagan O
    Rheumatol Int; 2003 Sep; 23(5):231-5. PubMed ID: 14504915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.